(Q45266089)

11 December 2017

Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B. (English)

1 reference

11 December 2017

1 reference

1 reference

1 reference

10

Kazuaki Chayama

1 reference

11 December 2017

2

Shinji Tanaka

1 reference

11 December 2017

8

Masaharu Yoshihara

1 reference

11 December 2017

7

Yasuhiko Kitadai

1 reference

11 December 2017

6

Masanori Ito

1 reference

11 December 2017

5

Toru Hiyama

1 reference

11 December 2017

1

Yoshitaka Ueno

1 reference

11 December 2017

9

Masaharu Sumii

1 reference

11 December 2017

4

Yoshihiro Miyanaka

1 reference

11 December 2017

3

Masaru Shimamoto

1 reference

11 December 2017

1 January 2005

1 reference

Digestive Diseases and Sciences

11 December 2017

1 reference

11 December 2017

50

1 reference

11 December 2017

1

1 reference

11 December 2017

163-166

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-005-1295-8

11 December 2017

0 references

cites work

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety

1 reference

12 December 2020

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

12 December 2020

Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures

1 reference

12 December 2020

Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate.

1 reference

12 December 2020

Effect of tumour necrosis factor antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection

1 reference

12 December 2020

Review article: safety of infliximab in clinical trials

1 reference

12 December 2020

Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C.

1 reference

12 December 2020

Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection

1 reference

12 December 2020

HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines

1 reference

12 December 2020

Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease.

1 reference

12 December 2020

Molecular therapeutics. Methotrexate and its mechanism of action

1 reference

12 December 2020

Treatment of patients with Crohn's disease and concomitant chronic hepatitis C with a chimeric monoclonal antibody to TNF

1 reference

12 December 2020

Infliximab maintenance therapy for fistulizing Crohn's disease

1 reference

12 December 2020

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

1 reference

12 December 2020

10.1007/S10620-005-1295-8

Identifiers

DOI

1 reference

PubMed ID

15712655

Dimensions Publication ID

11 December 2017

0 references

1 reference

PubMed ID

15712655